TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus” or “the Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), today ...
Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback